Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

被引：0
|
作者：
Kara N. Maxwell
Danielle Soucier-Ernst
Emin Tahirovic
Andrea B. Troxel
Candace Clark
Michael Feldman
Christopher Colameco
Bijal Kakrecha
Melissa Langer
David Lieberman
Jennifer J. D. Morrissette
Matt R. Paul
Tien-chi Pan
Stephanie Yee
Natalie Shih
Erica Carpenter
Lewis A. Chodosh
Angela DeMichele
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine, Division of Hematology
[2] Perelman School of Medicine at the University of Pennsylvania,Oncology
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology
[5] Perelman School of Medicine at the University of Pennsylvania,Department of Pathology and Laboratory Medicine
[6] Diabetes and Metabolism at the Perelman School of Medicine at the University of Pennsylvania,Department of Cancer Biology
[7] NYU School of Medicine,Department of Medicine, Division of Endocrinology
[8] University of Maryland School of Medicine,Department of Population Health
来源：
Breast Cancer Research and Treatment | 2017年 / 164卷
关键词：
Metastatic breast cancer; Liquid biopsy; Cell-free DNA; Genomic testing; Massively parallel sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 638
页数：11
相关论文
共 50 条
  • [1] Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
    Maxwell, Kara N.
    Soucier-Ernst, Danielle
    Tahirovic, Emin
    Troxel, Andrea B.
    Clark, Candace
    Feldman, Michael
    Colameco, Christopher
    Kakrecha, Bijal
    Langer, Melissa
    Lieberman, David
    Morrissette, Jennifer J. D.
    Paul, Matt R.
    Pan, Tien-chi
    Yee, Stephanie
    Shih, Natalie
    Carpenter, Erica
    Chodosh, Lewis A.
    DeMichele, Angela
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 627 - 638
  • [2] Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact
    Huebner, Hanna
    Wimberger, Pauline
    Laakmann, Elena
    Ruckhaeberle, Eugen
    Ruebner, Matthias
    Lehle, Sarah
    Uhrig, Sabrina
    Ziegler, Philipp
    Link, Theresa
    Hack, Carolin C.
    Belleville, Erik
    Faull, Iris
    Hausch, Marcus
    Wallwiener, Diethelm
    Schneeweiss, Andreas
    Tesch, Hans
    Brucker, Sara Y.
    Beckmann, Matthias W.
    Fasching, Peter A.
    Mueller, Volkmar
    Fehm, Tanja N.
    PRECISION CLINICAL MEDICINE, 2025, 8 (01)
  • [3] Circulating cell-free DNA and its clinical utility in cancer
    Salviano-Silva, Amanda
    Maire, Cecile L.
    Lamszus, Katrin
    Ricklefs, Franz L.
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (04) : 265 - 272
  • [4] The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer
    Laufer-Geva, Smadar
    Rozenblum, Anna Belilovski
    Twito, Tal
    Grinberg, Roxana
    Dvir, Addie
    Soussan-Gutman, Lior
    Ilouze, Maya
    Roisman, Laila C.
    Dudnik, Elizabeth
    Zer, Alona
    Rotem, Ofer
    Lanman, Richard B.
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1705 - 1716
  • [5] Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer
    Silveira, Catarina
    Sousa, Ana Carla
    Corredeira, Patricia
    Martins, Marta
    Sousa, Ana Rita
    Da Cruz Paula, Arnaud
    Selenica, Pier
    Brown, David N.
    Golkaram, Mahdi
    Kaplan, Shannon
    Zhang, Shile
    Liu, Li
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Costa, Luis
    Carmo-Fonseca, Maria
    BIOMOLECULES, 2022, 12 (12)
  • [6] Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
    Keup, Corinna
    Storbeck, Markus
    Hauch, Siegfried
    Hahn, Peter
    Sprenger-Haussels, Markus
    Tewes, Mitra
    Mach, Pawel
    Hoffmann, Oliver
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCERS, 2019, 11 (02):
  • [7] The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
    Gezer, Ugur
    Bronkhorst, Abel J.
    Holdenrieder, Stefan
    DIAGNOSTICS, 2022, 12 (06)
  • [8] Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
    Wang, Ru
    Li, Xiao
    Zhang, Huimin
    Wang, Ke
    He, Jianjun
    ONCOTARGET, 2017, 8 (43) : 75742 - 75755
  • [9] Clinical utility of plasma cell-free DNA in gliomas
    Carpenter, Erica L.
    Bagley, Stephen J.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 : 41 - 44
  • [10] Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients
    Lin, Shaoyan
    Wang, Shusen
    Xu, Binghe
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 563 - 569
12345